High levels of viral repression, malnutrition and second-line ART use in adolescents living with HIV: a mixed methods study from Myanmar

BMC Infect Dis. 2020 Mar 20;20(1):241. doi: 10.1186/s12879-020-04968-x.

Abstract

Background: Adolescents living with HIV/AIDS (ALHIV) are a particularly vulnerable but often overlooked group in the HIV response despite additional disease management challenges.

Methods: All ALHIV (10-19 years), on ART for ≥6 months, presenting to care at a Médecins Sans Frontières (MSF) clinic in Myanmar from January-April 2016 were eligible for the quantitative study component (clinical history, medical examination, laboratory investigation). A subset of these respondents were invited to participate in qualitative interviews. Interviews and focus groups were also conducted with other key informants (care givers, clinicians).

Results: Of 177 ALHIV, 56% (100) were aged 9-13 years and 77 (44%) were 14-19. 49% (86) had been orphaned by one parent, and 19% (33) by both. 59% (104) were severely underweight (BMI < 16). 47% presented with advanced HIV (WHO stage III/IV). 93% were virally supressed (< 250 copies/mL). 38 (21%) of ALHIV were on a second-line ART after first-line virological failure. Qualitative interviewing highlighted factors limiting adherence and the central role that HIV counsellors play for both ALHIV patients and caregivers.

Conclusions: Our study shows good clinical, immunological, and virological outcomes for a cohort of Myanmar adolescents living with HIV, despite a majority being severely underweight, presenting with Stage III or IV illness, and the prevalence of comorbid infections (TB). Many treatment and adherence challenges were articulated in qualitative interviewing but emphasized the importance of actively engaging adolescents in their treatment. Comprehensive HIV care for this population must include routine viral load testing and social support programs.

Keywords: ALHIV; Adherence; HIV/AIDS; Lipodystrophy; Qualitative; Teen clubs.

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / epidemiology*
  • Acquired Immunodeficiency Syndrome / microbiology
  • Adolescent
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use*
  • Body Mass Index
  • Caregivers
  • Child
  • Cohort Studies
  • Female
  • Focus Groups
  • Humans
  • Male
  • Malnutrition / epidemiology*
  • Medication Adherence
  • Myanmar / epidemiology
  • Prevalence
  • Treatment Outcome
  • Viral Load / drug effects*
  • Young Adult

Substances

  • Anti-HIV Agents